HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ataru Igarashi Selected Research

monooxyethylene trimethylolpropane tristearate (MTTS)

4/2022Drug Utilization and Medical Cost Study Focusing on Moisturizers in Cancer Patients Treated with Molecular Targeted Therapy: A Retrospective Observational Study Using Data from a Japanese Claims Database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ataru Igarashi Research Topics

Disease

8Rheumatoid Arthritis
04/2022 - 10/2010
7Neoplasms (Cancer)
04/2022 - 10/2007
5Pain (Aches)
01/2021 - 01/2015
4Neuralgia (Stump Neuralgia)
01/2019 - 01/2015
4Chronic Hepatitis C
01/2019 - 12/2016
3Gastroesophageal Reflux (GERD)
12/2019 - 08/2019
3Fibrosis (Cirrhosis)
01/2019 - 12/2016
2COVID-19
11/2022 - 01/2022
2Infections
11/2022 - 01/2021
2Asthma (Bronchial Asthma)
01/2022 - 01/2019
2Esophagitis
01/2022 - 08/2019
2Human Influenza (Influenza)
02/2021 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2015
2Dementia (Dementias)
01/2020 - 01/2015
2Neck Pain (Cervicalgia)
01/2019 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2017
2Low Back Pain (Lumbago)
01/2015 - 01/2015
2Coronary Disease (Coronary Heart Disease)
02/2014 - 01/2007
1Essential Hypertension
10/2022
1Rheumatic Diseases (Rheumatism)
04/2022
1Endometrial Neoplasms (Endometrial Cancer)
04/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Heartburn (Pyrosis)
01/2022
1Hemorrhage
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Ischemic Stroke
08/2021
1Patent Foramen Ovale
08/2021
1Lung Neoplasms (Lung Cancer)
04/2021
1Necrosis
03/2021
1Ulcerative Colitis
03/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Nutrition Disorders (Nutritional Disorders)
01/2021
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Type 2 Diabetes Mellitus (MODY)
10/2020
1Body Weight (Weight, Body)
10/2020
1Hypoglycemia (Reactive Hypoglycemia)
10/2020
1Weight Gain
10/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2020
1Weight Loss (Weight Reduction)
10/2020
1Malnutrition (Nutritional Deficiencies)
10/2019

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
04/2022 - 10/2010
4Proton Pump InhibitorsIBA
01/2022 - 08/2019
41- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2022 - 08/2019
4Adalimumab (Humira)FDA Link
03/2021 - 01/2017
4Pharmaceutical PreparationsIBA
02/2021 - 01/2015
4Pregabalin (Lyrica)FDA Link
01/2019 - 01/2015
3Rabeprazole (Aciphex)FDA Link
01/2022 - 08/2019
2VaccinesIBA
11/2022 - 01/2022
2Antirheumatic Agents (DMARD)IBA
04/2022 - 09/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 03/2021
2Infliximab (Remicade)FDA Link
03/2021 - 10/2018
2Antiviral Agents (Antivirals)IBA
02/2021 - 12/2016
2baloxavirIBA
02/2021 - 01/2021
2laninamivirIBA
02/2021 - 01/2021
2tisagenlecleucelIBA
01/2021 - 01/2021
2SofosbuvirIBA
01/2019 - 01/2017
2sofosbuvir drug combination ledipasvirIBA
01/2017 - 12/2016
12019-nCoV Vaccine mRNA-1273IBA
11/2022
1Messenger RNA (mRNA)IBA
11/2022
1COVID-19 VaccinesIBA
11/2022
1BNT162 VaccineIBA
11/2022
1monooxyethylene trimethylolpropane tristearate (MTTS)IBA
04/2022
1AcidsIBA
01/2022
1clonidine-displacing substance (ClDS)IBA
01/2022
1Omalizumab (Xolair)FDA Link
01/2022
1lusutrombopagIBA
01/2022
1PotassiumIBA
01/2022
1NivolumabIBA
08/2021
1trifluridine tipiracil drug combinationIBA
08/2021
1AntibodiesIBA
03/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1C-Reactive ProteinIBA
01/2021
1obinutuzumabIBA
10/2020
1semaglutideIBA
10/2020
1Rituximab (Mabthera)FDA Link
10/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2020
1Antineoplastic Agents (Antineoplastics)IBA
03/2020
1TropomyosinIBA
03/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2020
1Biomarkers (Surrogate Marker)IBA
03/2020
1Phosphotransferases (Kinase)IBA
03/2020
1Esomeprazole (Nexium)FDA Link
12/2019
1SDMIBA
10/2019
1ORALIT (ORS)IBA
08/2019

Therapy/Procedure

10Therapeutics
10/2022 - 10/2007
3Activities of Daily Living (ADL)
01/2021 - 01/2014
2Drug Therapy (Chemotherapy)
04/2022 - 10/2020
2Palliative Care (Palliative Therapy)
01/2022 - 01/2021
2Liver Transplantation
01/2019 - 01/2017
1Molecular Targeted Therapy
04/2022
1Platelet Transfusion (Blood Platelet Transfusions)
01/2022
1Terminal Care (Care, Terminal)
04/2021
1Glycemic Control
10/2020
1Injections
10/2020
1Immunotherapy
03/2020
1Long-Term Care
01/2020